David Clouston
-
- Prostate Cancer Treatment and Research 23
- Prostate Cancer Diagnosis and Treatment 18
- Renal cell carcinoma treatment 3
- Rheumatology top 5%
- Urologic and reproductive health conditions 9
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 4
- Urology top 5%
- Oncology top 10%
-
- BRCA gene mutations in cancer 6
-
- Genetic factors in colorectal cancer 6
-
- Bladder and Urothelial Cancer Treatments 3
- Co-authors
- Damien BoltonNathan LawrentschukRenea A. TaylorGail P. RisbridgerHeather ThorneStephen M. JaneMark FrydenbergMitchell G. Lawrence
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
David Clouston
48 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 80
- Pulmonary and Respiratory Medicine 557
- Rheumatology 209
- Cancer Research 202
- Urology 83
- Oncology 279
Countries citing papers authored by David Clouston
This map shows the geographic impact of David Clouston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Clouston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Clouston more than expected).
Fields of papers citing papers by David Clouston
This network shows the impact of papers produced by David Clouston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Clouston. The network helps show where David Clouston may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Clouston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 5 | |
| 4 | 2018 | 2 | |
| 5 | 2016 | 36 | |
| 6 | 2015 | 9 | |
| 7 | 2015 | 21 | |
| 8 | 2015 | 4 | |
| 9 | 2014 | 96 | |
| 10 | 2014 | 8 | |
| 11 | 2013 | 17 | |
| 12 | 2013 | 39 | |
| 13 | 2012 | 9 | |
| 14 | 2012 | 6 | |
| 15 | 2011 | 6 | |
| 16 | 2009 | 93 | |
| 17 | 2002 | 30 | |
| 18 | 2002 | 4 | |
| 19 | 1998 | 67 | |
| 20 | 1998 | 16 |
About David Clouston
David Clouston is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Pathology and Forensic Medicine, Cancer Research and Transplantation, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (23 papers), Prostate Cancer Diagnosis and Treatment (18 papers), Urologic and reproductive health conditions (9 papers), BRCA gene mutations in cancer (6 papers), Genetic factors in colorectal cancer (6 papers), Cancer Genomics and Diagnostics (4 papers), Renal cell carcinoma treatment (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (557 citations), Rheumatology (209 citations), Cancer Research (202 citations), Urology (83 citations) and Oncology (279 citations). David Clouston has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Damien Bolton, Nathan Lawrentschuk, Renea A. Taylor, Gail P. Risbridger, Heather Thorne, Stephen M. Jane, Mark Frydenberg, Mitchell G. Lawrence, John M. Cunningham and Anthony Hall. Their work appears in journals such as British Journal of Urology, Pathology, Prostate International, European Urology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.